UA110122C2 - Біциклічні похідні як анальгетики, фармацевтична композиція на їх основі та спосіб усунення болю - Google Patents

Біциклічні похідні як анальгетики, фармацевтична композиція на їх основі та спосіб усунення болю

Info

Publication number
UA110122C2
UA110122C2 UAA201308974A UAA201308974A UA110122C2 UA 110122 C2 UA110122 C2 UA 110122C2 UA A201308974 A UAA201308974 A UA A201308974A UA A201308974 A UAA201308974 A UA A201308974A UA 110122 C2 UA110122 C2 UA 110122C2
Authority
UA
Ukraine
Prior art keywords
analgetics
basis
pharmaceutical composition
bicyclic derivatives
pain removal
Prior art date
Application number
UAA201308974A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Жан Марі Дефо
Скот Дейл Холмстром
Шухой Чєнь
Ян ЧЖАН
Вєньтао У
Сянь Пен
Юйцзюань Ма
Лунь Лу
Original Assignee
Елі Ліллі Енд Компані
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Елі Ліллі Енд Компані filed Critical Елі Ліллі Енд Компані
Publication of UA110122C2 publication Critical patent/UA110122C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C219/30—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/20—All rings being cycloaliphatic the ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/50—Spiro compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UAA201308974A 2011-01-27 2012-01-13 Біциклічні похідні як анальгетики, фармацевтична композиція на їх основі та спосіб усунення болю UA110122C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2011/070706 WO2012100423A1 (en) 2011-01-27 2011-01-27 Analgesic compounds, methods, and formulations
PCT/US2012/021181 WO2012102875A2 (en) 2011-01-27 2012-01-13 Analgesic compounds, methods, and formulations

Publications (1)

Publication Number Publication Date
UA110122C2 true UA110122C2 (uk) 2015-11-25

Family

ID=45558412

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201308974A UA110122C2 (uk) 2011-01-27 2012-01-13 Біциклічні похідні як анальгетики, фармацевтична композиція на їх основі та спосіб усунення болю

Country Status (23)

Country Link
US (1) US8802728B2 (enExample)
EP (1) EP2668152B1 (enExample)
JP (1) JP6002153B2 (enExample)
KR (1) KR101612168B1 (enExample)
CN (2) CN105753723B (enExample)
AR (2) AR084815A1 (enExample)
AU (1) AU2012209430B2 (enExample)
BR (1) BR112013018527B1 (enExample)
CA (1) CA2825816C (enExample)
CL (1) CL2013002102A1 (enExample)
CO (1) CO6781505A2 (enExample)
EA (1) EA024101B1 (enExample)
ES (1) ES2612495T3 (enExample)
IL (1) IL227250A (enExample)
IN (1) IN2013MN01164A (enExample)
MX (1) MX345518B (enExample)
MY (1) MY163262A (enExample)
PH (1) PH12013501589A1 (enExample)
SG (1) SG192131A1 (enExample)
TW (1) TWI564275B (enExample)
UA (1) UA110122C2 (enExample)
WO (2) WO2012100423A1 (enExample)
ZA (1) ZA201304786B (enExample)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
DE1518663A1 (de) * 1965-08-02 1969-12-18 Gruenenthal Chemie Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
DE19547766A1 (de) * 1995-12-20 1997-06-26 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe
DE19805370A1 (de) * 1997-03-14 1998-09-17 Gruenenthal Gmbh Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
DE10049481A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte C-Cyclohexylmethylamin-Derivate
AU2002364517A1 (en) 2001-11-30 2003-06-17 Sepracor Inc. Tramadol analogs and uses thereof
US20050182131A1 (en) 2002-07-19 2005-08-18 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
DE10233048A1 (de) * 2002-07-19 2004-01-29 Grünenthal GmbH Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken
EP2022778A1 (en) * 2007-08-07 2009-02-11 Laboratorios del Dr. Esteve S.A. A crystalline form of (R,R)-tramadol-(S)-naproxene salt

Also Published As

Publication number Publication date
TWI564275B (zh) 2017-01-01
AU2012209430A1 (en) 2013-07-04
MX345518B (es) 2017-02-02
EP2668152A2 (en) 2013-12-04
BR112013018527A2 (pt) 2016-10-18
SG192131A1 (en) 2013-08-30
AU2012209430B2 (en) 2014-11-13
AR126189A2 (es) 2023-09-27
CN103328433B (zh) 2016-06-08
ES2612495T3 (es) 2017-05-17
CO6781505A2 (es) 2013-10-31
MY163262A (en) 2017-08-30
EA201390857A1 (ru) 2014-01-30
JP6002153B2 (ja) 2016-10-05
CA2825816A1 (en) 2012-08-02
PH12013501589A1 (en) 2013-09-30
IL227250A (en) 2015-03-31
JP2014511368A (ja) 2014-05-15
KR101612168B1 (ko) 2016-04-12
TW201242930A (en) 2012-11-01
CL2013002102A1 (es) 2014-06-27
CN103328433A (zh) 2013-09-25
US8802728B2 (en) 2014-08-12
BR112013018527B1 (pt) 2021-11-09
KR20130116348A (ko) 2013-10-23
ZA201304786B (en) 2014-12-23
EP2668152B1 (en) 2016-10-12
WO2012102875A2 (en) 2012-08-02
WO2012100423A1 (en) 2012-08-02
WO2012102875A3 (en) 2012-10-18
CA2825816C (en) 2016-08-09
CN105753723A (zh) 2016-07-13
AR084815A1 (es) 2013-06-26
CN105753723B (zh) 2018-11-06
US20130225679A1 (en) 2013-08-29
IN2013MN01164A (enExample) 2015-04-17
MX2013008708A (es) 2014-01-23
NZ612731A (en) 2015-04-24
EA024101B1 (ru) 2016-08-31

Similar Documents

Publication Publication Date Title
EA201291282A1 (ru) Азотсодержащие гетероарильные соединения
EA201390766A1 (ru) БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПОЛУЧЕНИЯ
EA201500265A1 (ru) Ингибиторы репликации вирусов гриппа
EA201491671A1 (ru) Гетероциклильные соединения
EA201590453A1 (ru) Конденсированные бициклические производные сульфамоила и их применение в качестве лекарственных препаратов для лечения гепатита b
EA201390934A1 (ru) Композиции и способы модулирования fxr
EA201290980A1 (ru) Производные 1-амино-2-циклопропилэтилбороновой кислоты
EA201690223A1 (ru) Ингибиторы фактора в комплемента на основе производных пиперидинилиндола и их применение
EA201491623A1 (ru) Замещенные пирролидин-2-карбоксамиды
EA201301209A1 (ru) Производные пирролотриазинона в качестве ингибиторов p13k
EA201790661A3 (ru) Ингибиторы вируса гепатита c
EA201490228A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
EA201201680A1 (ru) Морфолинопиримидины и их применение в терапии
EA201492287A1 (ru) Дейтерированные производные руксолитиниба
UA108640C2 (uk) Похідні n-(імідазопіримідин-7-іл)гетероариламідів та їх застосування як інгібіторів pde10a
EA201490471A1 (ru) Пиридазиноновые соединения и их применение в качестве ингибиторов daao
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
EA201290416A1 (ru) Новые спиропиперидиновые соединения
EA201690521A1 (ru) Способ получения замещенных 5-фтор-1h-пиразолопиридинов
EA201400771A1 (ru) Новые производные азетидина, фармацевтические композиции и их применение
EA201490650A1 (ru) Фармацевтические композиции
UA109037C2 (uk) Триазолопіридини
EA201490599A1 (ru) Соединения триазолопиридина в качестве ингибиторов фосфодиэстеразы pde10a
EA201891804A1 (ru) Тетрациклиновые соединения
EA201591259A1 (ru) Твёрдые формы производного хиназолина и их применение в качестве ингибитора braf